(Created page with "{{Medical Device |Health Topic=Child mortality, |Classification=Preventative |Scope=Clinical trial |Location=Africa |Image=Antiretroviral pouch.jpg }} <!-- Please make sure to u...") |
(re-saving to fix a problem with semantic mediawiki) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{Medical Device | {{Medical Device | ||
|Health Topic=Child mortality | |Health Topic=Child mortality | ||
|Classification=Preventative | |Classification=Preventative | ||
|Scope=Clinical trial | |Scope=Clinical trial | ||
| Line 26: | Line 26: | ||
Malkin, R. A., & Gamache, C. C. Novel packaging of single infant dose nevirapine to prevent HIV transmission from mother to child in resource-constrained settings. Retrieved from http://dhtlab.pratt.duke.edu/sites/dhtlab.pratt.duke.edu/files/Full paper AHT Final.pdf | Malkin, R. A., & Gamache, C. C. Novel packaging of single infant dose nevirapine to prevent HIV transmission from mother to child in resource-constrained settings. Retrieved from http://dhtlab.pratt.duke.edu/sites/dhtlab.pratt.duke.edu/files/Full paper AHT Final.pdf | ||
===Externally generated reports=== | ===Externally generated reports=== | ||
Novel approach tests mother-to-newborn | Novel approach tests mother-to-newborn HIV spread prevention. (August 23, 2011) Retrieved from http://www.pratt.duke.edu/news/novel-approach-tests-mother-newborn-hiv-spread-prevention | ||
===IP and copyright=== | ===IP and copyright=== | ||
===Approval by regulatory bodies or standards boards=== | ===Approval by regulatory bodies or standards boards=== | ||
<!-- Add relevant categories, such as [[Category:HIV]] or [[Category:Malaria]] below this line --> | <!-- Add relevant categories, such as [[Category:HIV]] or [[Category:Malaria]] below this line --> | ||
Revision as of 20:09, 19 November 2013
Problem being addressed
Research shows that children in Africa that are born at home are extremely unlikely to receive drugs within 24 hours of birth to prevent the spread of HIV from mother to child. Because conventional containers cannot store the drug because they destroy the active ingredient, the only way for mothers to administer the antiretroviral drugs to their newborn child is to travel to a clinic immediately after birth. This is often quite difficult and leaves millions of infants at risk of becoming HIV+ during the birthing process.
Detailed description of the solution
The Pratt Pouch is a foil pouch lined with plastic that holds a dose of anti-retroviral medication. The pouch resembles a ketchup packet and can effectively store the medication to prevent mother-to-child transmission of HIV for months. If a mother cannot make it to a hospital to deliver her child, she can simply tear open the packet and distribute the drugs to her newborn.
Designed by
- Designed by: Developing World Healthcare Technology Laboratory, Duke University
- Manufacturer (if different):
- Manufacturer location: Developing World Healthcare Technology Laboratory, Duke University
When and where it was tested/implemented
Field testing is being done in Tanzania.
Funding Source
Duke University
References
Peer-reviewed publication
Other internally generated reports
Malkin, R. A., & Gamache, C. C. Novel packaging of single infant dose nevirapine to prevent HIV transmission from mother to child in resource-constrained settings. Retrieved from http://dhtlab.pratt.duke.edu/sites/dhtlab.pratt.duke.edu/files/Full paper AHT Final.pdf
Externally generated reports
Novel approach tests mother-to-newborn HIV spread prevention. (August 23, 2011) Retrieved from http://www.pratt.duke.edu/news/novel-approach-tests-mother-newborn-hiv-spread-prevention